EPISODE · Mar 2, 2026 · 6 MIN
今天3分钟我们来聊聊全球首个！DM1治疗迎来分子级突破
from 源于细胞BioInsid的个人播客
NEJM报道全球首个"抗体+寡核苷酸"治疗1型强直性肌营养不良症的里程碑研究。AOC 1001精准递送siRNA降解毒性mRNA，临床试验显示DMPK mRNA显著下降，剪接异常改善，为无药可治的遗传病带来新希望。前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊全球首个！DM1治疗迎来分子级突破
0:00
6:18
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 6 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on March 2, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!